Oric Pharmaceuticals Valuation
| ORIC Stock | USD 9.97 0.17 1.73% |
At this time, the company appears to be undervalued. Oric Pharmaceuticals holds a recent Real Value of $12.06 per share. The prevailing price of the company is $9.97. Our model determines the value of Oric Pharmaceuticals from analyzing the company fundamentals such as Return On Equity of -0.46, shares owned by institutions of 90.88 %, and Shares Outstanding of 70.57 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Oric Pharmaceuticals' valuation include:
Price Book 2.524 | Enterprise Value 422.3 M | Enterprise Value Ebitda 0.1311 |
Undervalued
Today
Please note that Oric Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Oric Pharmaceuticals is based on 3 months time horizon. Increasing Oric Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Oric Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Oric Stock. However, Oric Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.97 | Real 12.06 | Target 15.86 | Hype 9.97 |
The real value of Oric Stock, also known as its intrinsic value, is the underlying worth of Oric Pharmaceuticals Company, which is reflected in its stock price. It is based on Oric Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Oric Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Oric Pharmaceuticals helps investors to forecast how Oric stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Oric Pharmaceuticals more accurately as focusing exclusively on Oric Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Oric Pharmaceuticals' intrinsic value based on its ongoing forecasts of Oric Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Oric Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Oric Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Oric Pharmaceuticals Cash |
|
Oric Valuation Trend
Comparing Oric Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Oric Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Oric Pharmaceuticals Total Value Analysis
Oric Pharmaceuticals is now forecasted to have valuation of 422.31 M with market capitalization of 703.55 M, debt of 10.21 M, and cash on hands of 227.06 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Oric Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
422.31 M | 703.55 M | 10.21 M | 227.06 M |
Oric Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Oric is to check how much profit was generated for every dollar of assets it reports. Oric Pharmaceuticals holds a negative application of assets of -0.29 pct., losing $0.002922 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Oric Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Oric Pharmaceuticals Ownership Allocation
The majority of Oric Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Oric Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Oric Pharmaceuticals. Please pay attention to any change in the institutional holdings of Oric Pharmaceuticals as this could imply that something significant has changed or is about to change at the company.Oric Pharmaceuticals Profitability Analysis
Net Loss for the year was (100.7 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Oric Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Oric Pharmaceuticals and how it compares across the competition.
About Oric Pharmaceuticals Valuation
The stock valuation mechanism determines Oric Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Oric Pharmaceuticals. We calculate exposure to Oric Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Oric Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1 M | -1.1 M |
Oric Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 51.5 M |
Oric Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Oric Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Oric we look at many different elements of the entity such as Oric's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Oric Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Oric Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Oric Pharmaceuticals' worth.Complementary Tools for Oric Stock analysis
When running Oric Pharmaceuticals' price analysis, check to measure Oric Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oric Pharmaceuticals is operating at the current time. Most of Oric Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oric Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oric Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oric Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |